focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
think either way ,once fda approval has been gotten ,and then dual listing the potential here can actually start .
most recent rns indicates that OTHERS ARE MASSIVELY interested in our system ( this cannot be under emphasised 1) and an income which alleviates hopefully minor fundings/dilution ( yes i know we have cash and from when but it will be intersting to see Q1 figures for income then etc etc ).
the secrecy of our new client also can be open to suggestion as another posted intimated a share price increase .
i have monies elswhere ie gdr and dest to once they have exhausted themselves to invest in here ,gla
So prelims and Q&A session , does anyone envisage more contractual news prior to this ?
A posted a few days ago that I did not and lo and behold The First Sign of a Metamorphosis for AGL being much different than beforehand
Well the RNS prior to this one is the AACR 21 announcement, prior to this we had an abundance of papers supporting AGL , all helping and adding to our FDA Approval.
So whether we have enough is to be seen .
Cannot envisage much to be seen re past years financially side .
Anyway fingers crossed for a nugget of news prior to fruition of today’s news .
Few big trades , possibly an ISA transfer
https://www.abstractsonline.com/pp8/#!/9325?utm_source=T&utm_medium=P&utm_campaign=AACR21B
Bravo ,Brilliant premis of sorts of what AGl have ongoing and hopefully sooner rather than later update and confirm all of these .
will be interesting to see Q updates on incomes and contracts after FDA and pharma services .
the majors use minors for wildcatting and exploration and the use of new drilling equipment and technology ,thats the risk .
i very much doubt an offer is being tabled and if so a derisory price ,take the money and run if it goes up today